Literature DB >> 16520920

To: Scholtz HE, Pretorius SG, Wessels DH, Becker RHA (2005) Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique. Diabetologia 48:1988-1995.

J H DeVries.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16520920     DOI： 10.1007/s00125-006-0166-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  3 in total

1.  Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique.

Authors:  H E Scholtz; S G Pretorius; D H Wessels; R H A Becker
Journal:  Diabetologia       Date:  2005-09-14       Impact factor: 10.122

2.  Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Authors:  M Lepore; S Pampanelli; C Fanelli; F Porcellati; L Bartocci; A Di Vincenzo; C Cordoni; E Costa; P Brunetti; G B Bolli
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

3.  Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

Authors:  Tim Heise; Leszek Nosek; Birgitte Biilmann Rønn; Lars Endahl; Lutz Heinemann; Christoph Kapitza; Eberhard Draeger
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461
  3 in total
  4 in total

1.  Nice insulins, pity about the evidence.

Authors:  F Holleman; E A M Gale
Journal:  Diabetologia       Date:  2007-09       Impact factor: 10.122

2.  The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back.

Authors:  S G H A Swinnen; F Holleman; J H DeVries
Journal:  Diabetologia       Date:  2008-08-01       Impact factor: 10.122

Review 3.  New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations.

Authors:  Paris Roach
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 4.  Insulin therapy for type 2 diabetes.

Authors:  Sanne G Swinnen; Joost B Hoekstra; J Hans DeVries
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.